675616-37-2

Basic information

• Product Name: Benzoic acid, 2-bromo-3,4,5-tris(phenylmethoxy)-, methyl ester
• CAS NO: 675616-37-2
• Molecular Formula: C29H25BrO5
• Molecular Weight: 533.418
• Mol File: 675616-37-2.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 2-bromo-3,4,5-tris(phenylmethoxy)-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2-bromo-3,4,5-tris(phenylmethoxy)-, methyl ester(675616-37-2)
• EPA Substance Registry System: Benzoic acid, 2-bromo-3,4,5-tris(phenylmethoxy)-, methyl ester(675616-37-2)

Safety Data

• Hazardous Substances Data: 675616-37-2(Hazardous Substances Data)

Upstream product

• 100-39-0 benzyl bromide 
• 99-24-1 methyl galloate 
• 70424-94-1 methyl 3,4,5-tris(benzyloxy)benzoate 

Downstream Products

• 219781-78-9 methyl 3,4,5-tribenzyloxy-2-(2,3-dibenzyloxy-5-methoxycarbonylphenoxy)benzoate 
• 675616-38-3 (E)-methyl 2-(1-octen-1-yl)-3,4,5-tribenzyloxybenzoate 
• 70424-94-1 methyl 3,4,5-tris(benzyloxy)benzoate 
• 97152-19-7 dimethyl 4,4',5,5',6,6'-hexakis(benzyloxy)-[1,1'-biphenyl]-2,2'-dicarboxylate 
• 476-66-4 ellagic acid 
• 5693-34-5 dehydrodigallic acid 
• 1676106-70-9 C₄₂H₃₂O₁₀ 
• 1606148-49-5 methyl 3,4,5-tribenzyloxy-2-(2,3-p-methoxybenzyloxo-5-methoxycarbonylphenoxy) benzoate 
• 1606148-48-4 methyl 2-(2,3-benzyloxy-5-methoxycarbonylphenoxy)-3,4,5-tribenzyloxybenzoate 
• 1606148-47-3 methyl 3,4,5-tribenzyloxy-2-(2,3-ethoxymethylenedioxy-5-methoxycarbonylphenoxy) benzoate 
• 1606148-46-2 methyl 3,4,5-tribenzyloxy-2-(2,3-dimethoxy-5-methoxycarbonylphenoxy)benzoate 
• 1034402-65-7 3,4,5-tris(benzyloxy)-2-bromobenzoic acid 

Relevant articles and documents

Synthetic Ellagic Acid Glycosides Inhibit Early Stage Adhesion of Streptococcus agalactiae Biofilms as Observed by Scanning Electron Microscopy

Ellagic acid derivatives possess antimicrobial and antibiofilm properties across a wide-range of microbial pathogens. Due to their poor solubility and ambident reactivity it is challenging to synthesize, purify, and characterize the activity of ellagic acid glycosides. In this study, we have synthesized three ellagic acid glycoconjugates and evaluated their antimicrobial and antibiofilm activity in Streptococcus agalactiae (Group B Streptococcus, GBS). Their significant impacts on biofilm formation were examined via SEM to reveal early-stage inhibition of cellular adhesion. Additionally, the synthetic glycosides were evaluated against five of the six ESKAPE pathogens and two fungal pathogens. These studies reveal that the ellagic acid glycosides possess inhibitory effects on the growth of gram-negative pathogens.

Total synthesis of sanguiin H-5

(Chemical Equation Presented) Using an atropdiastereoselective oxidative biaryl coupling as the key step, the total synthesis of the ellagitannin natural product sanguiin H-5 is reported. Both organomagnesium and organozinc based metalation methodologies

Synthetic racemate and enantiomers of cytosporone E, a metabolite of an endophytic fungus, show indistinguishably weak antimicrobial activity

The racemate and the enantiomers of cytosporone E [3-heptyl-4,5,6- trihydroxyphthalide (1)], a metabolite of the endophytic fungus, CR200 (Cytospora sp.), were synthesized. The key steps were (i) Sharpless asymmetric dihydroxylation of an alkene (8) and (